logo

For the Inventor, By the Inventor

Basel, Switzerland

Pentapharm Ag


USPTO Granted Patents = 32

% Expired Patents = 3.1

Trademarks = 17

Forward Citations = 478

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Lars G Svendsen (12 out of 12 patents)

silverMedal Kurt F Stocker (8 out of 9 patents)

bronzeMedal Peter Wikstroem (3 out of 13 patents)

4.  Douglas A Triplett (3 out of 3 patents)

5.  Helmut Vieweg (2 out of 4 patents)

6.  Thomas Schreier (2 out of 2 patents)

7.  Rainer Voegeli (2 out of 2 patents)

8.  Peter E Ries (2 out of 2 patents)

9.  Andreas Calatzis (1 out of 13 patents)

10.  Hugo Ziegler (1 out of 39 patents)

11.  Roland Jermann (1 out of 2 patents)

12.  Jörg Stürzebecher (1 out of 7 patents)

13.  Patrizia Maria Gempeler (1 out of 1 patent)

14.  Carlo Ghisalberti (1 out of 2 patents)

15.  Franck Moisio (1 out of 1 patent)


Core Competencies:
Anticoagulants
Hematological Assay
Peptide Derivatives
Thrombin Inhibitors
Protein C System
Electrochemical Measurement
Self-Tanning Properties
Lyophilized Products
Cosmetic Care
Collagen Products
Enzyme Assays
Protease Activity

32 patents:

1. 11846640 - Identification of anticoagulants in a sample (2023-12-19),
2. 6994984 - Hematological assay (2006-02-07),
3. 6953583 - Use of conjugated linoleic acid (CLA) for the topical treatment of cellulite (2005-10-11),
4. 6880728 - Closure cap (2005-04-19),
5. 6861435 - Urokinase inhibitors (2005-03-01),
6. 6495336 - Oligopeptide derivatives for the electrochemical measurement of protease activity (2002-12-17),
7. 6451559 - Expression vector for improved production of polypeptides in yeast (2002-09-17),
8. 6451293 - Combination of erythrulose and a reducing sugar with self-tanning properties (2002-09-17),
9. 6426192 - Method for the functional detection of disorders in the protein C system (2002-07-30),
10. 6237649 - Dual vial connecting system for lyophilized products (2001-05-29),
11. 5922587 - Phospholipid dependent prothrombin activator obtained from snake venom (1999-07-13),
12. 5705198 - Test for lupus anticoagulant (1998-01-06),
13. 5607937 - Piperazides of substituted phenylalanine derivatives as thrombin (1997-03-04),
14. 5518735 - Meta-substituted phenylalanine derivatives (1996-05-21),
15. 5453370 - Method for the preparation of a phospholipid-dependent prothrombin (1995-09-26),
Pentapharm AG, based in Basel, Switzerland, specializes in the development and manufacturing of high-quality active pharmaceutical ingredients and excipients. The company focuses on innovative solutions for the pharmaceutical and cosmetic industries, leveraging advanced technologies to enhance product efficacy and safety. With a commitment to research and development, Pentapharm AG aims to address the evolving needs of its clients while adhering to stringent quality standards in a competitive global market.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Pentapharm Ag
32 Patents

#18 in Basel

#424 in Switzerland

#20,645 in the World

Basel, CH
Basel, Switzerland

Pentapharm Ag

Forward Citations = 478

29 inventors:

goldMedal Lars G Svendsen (12 out of 12 patents)

silverMedal Kurt F Stocker (8 out of 9 patents)

bronzeMedal Peter Wikstroem (3 out of 13 patents)

4.  Douglas A Triplett (3 out of 3 patents)

5.  Helmut Vieweg (2 out of 4 patents)

Please report any incorrect information to [email protected]
Loading…